Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Helicobacter pylori testing industry 3600 synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Test type trends
2.2.2 Method trends
2.2.3 End-use trends
2.2.4 Regional trends
Chapter 3 Helicobacter Pylori Testing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rise in prevalence of gastric ulcer
3.3.1.2 Increasing geriatric population at risk
3.3.1.3 Growing demand for point-of-care testing devices
3.3.1.4 Rising adoption of non-invasive H. pylori testing
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of skilled professionals for invasive testing
3.3.2.2 Lack of awareness regarding H. pylori infection
3.4 Growth potential analysis
3.4.1 By test type
3.4.2 By method
3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Pricing analysis
3.10 Gap analysis
3.11 Porter's Analysis
3.12 PESTLE Analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Company market share analysis, 2021
4.4 Strategy dashboard, 2021
Chapter 5 Helicobacter Pylori Testing Market, By Test Type
5.1 Key segment trends
5.2 Invasive
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.2 Histology
5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.3 Rapid Urease Test
5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.2.4 HP Culture
5.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Non-invasive
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.2 Serologic Test
5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.3 Urea Breath Test
5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.3.4 Stool/Fecal Antigen Test
5.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Helicobacter Pylori Testing Market, By Method
6.1 Key segment trends
6.2 Point of care (POC) Tests
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Laboratory Based Tests
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Helicobacter Pylori Testing Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Clinics
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Diagnostic labs
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Helicobacter Pylori Testing Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 - 2032 (USD Million)
8.2.2 Market size, by test type, 2018 - 2032 (USD Million)
8.2.2.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.2.2.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.3 Market size, by method, 2018 - 2032 (USD Million)
8.2.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by test type, 2018 - 2032 (USD Million)
8.2.5.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.2.5.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by method, 2018 - 2032 (USD Million)
8.2.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by test type, 2018 - 2032 (USD Million)
8.2.6.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.2.6.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by method, 2018 - 2032 (USD Million)
8.2.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 - 2032 (USD Million)
8.3.2 Market size, by test type, 2018 - 2032 (USD Million)
8.3.2.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.2.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.3 Market size, by method, 2018 - 2032 (USD Million)
8.3.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.5.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.5.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.6.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.6.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.7.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.7.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.8.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.8.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.9.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.9.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.10 Poland
8.3.10.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.10.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.10.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.10.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.10.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.11 Romania
8.3.11.1 Market size, by test type, 2018 - 2032 (USD Million)
8.3.11.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.3.11.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.11.2 Market size, by method, 2018 - 2032 (USD Million)
8.3.11.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 - 2032 (USD Million)
8.4.2 Market size, by test type, 2018 - 2032 (USD Million)
8.4.2.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.4.2.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.3 Market size, by method, 2018 - 2032 (USD Million)
8.4.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.5 China
8.4.5.1 Market size, by test type, 2018 - 2032 (USD Million)
8.4.5.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.4.5.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by method, 2018 - 2032 (USD Million)
8.4.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by test type, 2018 - 2032 (USD Million)
8.4.6.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.4.6.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by method, 2018 - 2032 (USD Million)
8.4.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by test type, 2018 - 2032 (USD Million)
8.4.7.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.4.7.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by method, 2018 - 2032 (USD Million)
8.4.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.8 South Korea
8.4.8.1 Market size, by test type, 2018 - 2032 (USD Million)
8.4.8.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.4.8.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by method, 2018 - 2032 (USD Million)
8.4.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.9 Australia
8.4.9.1 Market size, by test type, 2018 - 2032 (USD Million)
8.4.9.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.4.9.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.9.2 Market size, by method, 2018 - 2032 (USD Million)
8.4.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 - 2032 (USD Million)
8.5.2 Market size, by test type, 2018 - 2032 (USD Million)
8.5.2.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.5.2.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.3 Market size, by method, 2018 - 2032 (USD Million)
8.5.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by test type, 2018 - 2032 (USD Million)
8.5.5.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.5.5.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by method, 2018 - 2032 (USD Million)
8.5.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.6 Chile
8.5.6.1 Market size, by test type, 2018 - 2032 (USD Million)
8.5.6.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.5.6.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by method, 2018 - 2032 (USD Million)
8.5.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.7 Argentina
8.5.7.1 Market size, by test type, 2018 - 2032 (USD Million)
8.5.7.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.5.7.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.7.2 Market size, by method, 2018 - 2032 (USD Million)
8.5.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.8 Mexico
8.5.8.1 Market size, by test type, 2018 - 2032 (USD Million)
8.5.8.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.5.8.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.8.2 Market size, by method, 2018 - 2032 (USD Million)
8.5.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6 Middle East & Africa
8.6.1 Market size, by country, 2018 - 2032 (USD Million)
8.6.2 Market size, by test type, 2018 - 2032 (USD Million)
8.6.2.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.6.2.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.3 Market size, by method, 2018 - 2032 (USD Million)
8.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.5 Saudi Arabia
8.6.5.1 Market size, by test type, 2018 - 2032 (USD Million)
8.6.5.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.6.5.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by method, 2018 - 2032 (USD Million)
8.6.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by test type, 2018 - 2032 (USD Million)
8.6.6.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.6.6.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by method, 2018 - 2032 (USD Million)
8.6.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.7 Nigeria
8.6.7.1 Market size, by test type, 2018 - 2032 (USD Million)
8.6.7.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.6.7.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.7.2 Market size, by method, 2018 - 2032 (USD Million)
8.6.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.8 Turkey
8.6.8.1 Market size, by test type, 2018 - 2032 (USD Million)
8.6.8.1.1 Market size, by invasive, 2018 - 2032 (USD Million)
8.6.8.1.2 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.8.2 Market size, by method, 2018 - 2032 (USD Million)
8.6.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Business Overview
9.1.2 Financial Data
9.1.3 Product Landscape
9.1.4 Strategic Outlook
9.1.5 SWOT Analysis
9.2 Avanos Corporate
9.2.1 Business Overview
9.2.2 Financial Data
9.2.3 Product Landscape
9.2.4 Strategic Outlook
9.2.5 SWOT Analysis
9.3 Biohit Oyj
9.3.1 Business Overview
9.3.2 Financial Data
9.3.3 Product Landscape
9.3.4 Strategic Outlook
9.3.5 SWOT Analysis
9.4 Bio-Rad Laboratories, Inc.
9.4.1 Business Overview
9.4.2 Financial Data
9.4.3 Product Landscape
9.4.4 Strategic Outlook
9.4.5 SWOT Analysis
9.5 Cardinal Health, Inc.
9.5.1 Business Overview
9.5.2 Financial Data
9.5.3 Product Landscape
9.5.4 Strategic Outlook
9.5.5 SWOT Analysis
9.6 bioMerieux SA
9.6.1 Business Overview
9.6.2 Financial Data
9.6.3 Product Landscape
9.6.4 Strategic Outlook
9.6.5 SWOT Analysis
9.7 Gulf Coast Scientific
9.7.1 Business Overview
9.7.2 Financial Data
9.7.3 Product Landscape
9.7.4 Strategic Outlook
9.7.5 SWOT Analysis
9.8 Medline Industries
9.8.1 Business Overview
9.8.2 Financial Data
9.8.3 Product Landscape
9.8.4 Strategic Outlook
9.8.5 SWOT Analysis
9.9 Meridian Biosciences, Inc.
9.9.1 Business Overview
9.9.2 Financial Data
9.9.3 Product Landscape
9.9.4 Strategic Outlook
9.9.5 SWOT Analysis
9.10 Quidel Corporation
9.10.1 Business Overview
9.10.2 Financial Data
9.10.3 Product Landscape
9.10.4 Strategic Outlook
9.10.5 SWOT Analysis
9.11 ThermoFischer Scientific Corporation
9.11.1 Business Overview
9.11.2 Financial Data
9.11.3 Product Landscape
9.11.4 Strategic Outlook
9.11.5 SWOT Analysis
9.12 Laboratory Corporation of America, Inc.
9.12.1 Business Overview
9.12.2 Financial Data
9.12.3 Product Landscape
9.12.4 Strategic Outlook
9.12.5 SWOT Analysis
9.13 AdvancePharma
9.13.1 Business Overview
9.13.2 Financial Data
9.13.3 Product Landscape
9.13.4 Strategic Outlook
9.13.5 SWOT Analysis
9.14 Epitope Diagnostics
9.14.1 Business Overview
9.14.2 Financial Data
9.14.3 Product Landscape
9.14.4 Strategic Outlook
9.14.5. SWOT Analysis
9.15 TECHLAB, Inc.
9.15.1 Business Overview
9.15.2 Financial Data
9.15.3 Product Landscape
9.15.4 Strategic Outlook
9.15.5 SWOT Analysis
